Your session is about to expire
← Back to Search
Erector spinae plane catheter with 0.5% Ropivacaine for Mitral Valve Regurgitation
N/A
Waitlist Available
Led By Wilson Cui, MD, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours
Awards & highlights
Study Summary
This study is evaluating whether a local anesthetic injection may help reduce pain and other complications following minimally invasive mitral valve surgery.
Eligible Conditions
- Mitral Valve Regurgitation
- Mitral Valve Prolapse
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 48 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Total opiate consumption
Secondary outcome measures
Length of hospital stay
Length of intensive care stay
Pain score
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ESP + CryoablationExperimental Treatment1 Intervention
2. Cryoablation of intercostal nerves + ESP catheter with local anesthetic infusion.
Group II: CryoablationPlacebo Group1 Intervention
1. Cryoablation of intercostal nerves + Sham ESP catheter with saline infusion.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,505 Total Patients Enrolled
Wilson Cui, MD, PhDPrincipal InvestigatorUniversity of California, San Francisco
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger